Plus Therapeutics Grants 300K Options and 300K RSUs with $0.243 Strike
Plus Therapeutics granted inducement awards of 300,000 stock options and 300,000 RSUs to two new hires on March 26, 2026 under its 2015 Incentive Plan. Options carry a 10-year term at $0.243 exercise price vesting over four years and RSUs vest over three years under a graded schedule.
1. Grant of Inducement Awards
On March 26, 2026, Plus Therapeutics’ Compensation Committee approved inducement awards under its 2015 New Employee Incentive Plan, granting two new employees a total of 300,000 stock options and 300,000 restricted stock units.
2. Option Terms and Vesting
The awarded stock options carry a ten-year term with an exercise price of $0.243 per share and vest over four years, with 25% of the options vesting on the first anniversary of the grant and the remainder vesting in equal monthly installments.
3. RSU Vesting Schedule
Each restricted stock unit represents a claim to one share of common stock, vesting over three years with one-third of the units vesting on the first anniversary of the grant and the remaining two-thirds vesting ratably over the following eight fiscal quarters.